The story of Viagra presents a challenging picture for investors. While the initial launch generated massive returns, the end of its patent opened the avenue to cheaper competitors, dramatically reducing market share. https://yesbookmarks.com/story21728274/viagra-and-big-pharma-a-volatile-opportunity